T-group (topology)
101.1.9 Putative DNA-binding domain
Ligands and drugs
3,895
Member domains
176
with ligand contacts (≤ 4 Å)
4.5% of members
153
with DrugDomain annotations
3.9% of members
61
with a DrugBank compound
1.6% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 101.1.9 belongs to X-group 101 HTH, which binds 8.7 ligand superclasses per 20 proteins, broader than 73% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00120 | — | Phenylalanine | 2 |
| DB02893 | MED | D-Methionine | 2 |
| DB04349 | PGO | (S)-propane-1,2-diol | 2 |
| DB04447 | DTT | 1,4-Dithiothreitol | 2 |
| DB00131 | AMP | Adenosine phosphate | 1 |
| DB02210 | HEZ | Hexane-1,6-Diol | 1 |
| DB02219 | CXS | 3-(cyclohexylamino)propanesulfonic acid | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 61 |
| ZNmetal | ZINC ION | 13 |
| PBmetal | LEAD (II) ION | 8 |
| AGmetal | SILVER ION | 6 |
| BR | BROMIDE ION | 6 |
| CL | CHLORIDE ION | 6 |
| HGmetal | MERCURY (II) ION | 6 |
| CAmetal | CALCIUM ION | 4 |
| CDmetal | CADMIUM ION | 4 |
| CUmetal | COPPER (II) ION | 4 |
| MNmetal | MANGANESE (II) ION | 4 |
| C2E | 9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin-6-one) | 3 |
| P4P | TETRAPHENYLPHOSPHONIUM | 3 |
| AUmetal | GOLD ION | 2 |
| CU1metal | COPPER (I) ION | 2 |
| DTT | 2,3-DIHYDROXY-1,4-DITHIOBUTANE | 2 |
| FES | FE2/S2 (INORGANIC) CLUSTER | 2 |
| HEZ | HEXANE-1,6-DIOL | 2 |
| NAmetal | SODIUM ION | 2 |
| PGO | S-1,2-PROPANEDIOL | 2 |